Skip to main content
Log in

Effect of IL-10 on formation of foam cell induced by ox-LDL

  • Research Article
  • Published:
Frontiers of Medicine in China Aims and scope Submit manuscript

Abstract

Atherosclerosis is a chronic disease that causes various cardiovascular complications. It has been realized that cellular and humoral immunity plays crucial roles in atherogenic lesion formation. In this study the effects of lipopolysaccharide (LPS) and interleukin-10 (IL-10) on the formation of foam cells during the early stages of atherosclerosis have been investigated. Macrophage was induced by phorbol myristate acetate (PMA) treatment on THP-1 cells. The cells were further stimulated by ox-LDL, ox-LDL plus LPS, ox-LDL plus IL-10 and LPS. By using an oil red O staining technique, the formation of foam cells was evaluated by lipid granules formation in the cells. The ratio of foam cell formation was increased from (9.77 ± 1.70)% to (16.27 ± 2.27)% after 24 h stimulation with ox-LDL, and the increase was observed with incubating time. The foam cells were significantly increased in the presence of LPS in a dose-dependent manner. The maximum increase of about 40% was observed. However, the significant elevation by LPS was abrogated when IL-10 was added. These results indicated that IL-10 can effectively prevent the formation of foam cells induced by ox-LDL with or without LPS. This study demonstrates that ox-LDL can cause foam cell formation from macrophages in vitro. LPS can significantly accelerate this event. IL-10, an anti-inflammatory cytokine, can inhibit the effect of ox-LDL and LPS. These results indicate that inflammatory effects in blood vessels can speed up foam cell formation. The inhibitive effect of IL-10 is an important factor for delaying atherosclerosis processes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Glass C K, Witztum J L. Atherosclerosis. the road ahead. Cell, 2001, 104(4): 503–516

    Article  PubMed  CAS  Google Scholar 

  2. Hansson G K. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol, 2001, 21(12): 1876–1890

    Article  PubMed  CAS  Google Scholar 

  3. Frostegard J. Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmun Rev, 2002, 1(4): 223–237

    Article  Google Scholar 

  4. Fichtlscherer S, Breuer S, Heeschen C, Dimmeler S, Zeiher A M. Interleukin-10 serum Levels and systemic Endothelial vasoreactivity in patients with coronary artery disease. J Am Coll Cardiol, 2004, 44(1): 44–49

    Article  PubMed  CAS  Google Scholar 

  5. Anguera I, Miranda-Guardiola F, Bosch X, Filella X, Sitges M, Marín J L, Betriu A, Sanz G. Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. Am Heart J, 2002, 144(5): 811–817

    PubMed  Google Scholar 

  6. Heesche C, Dimmeler S, Hamm C W, Fichtlscherer S, Boersma E, Simoons M, Zeiher A. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation, 2003, 107(16): 2109–2114

    Article  Google Scholar 

  7. Von Der Thusen J H, Kuiper J, Fekkes M L, Vos P D, Van Berkel T J C and Biessen E A L. Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/-mice. FASEB J, 2001, 15(14): 2730–3732

    Google Scholar 

  8. Pinderski L J, Fischbein M P, Subbanagounder G, Fishbein M C, Kubo N, Cheroutre H, Curtiss L K, Berliner J A, Boisvert W A. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res, 2002, 90(10): 1064–1071

    Article  PubMed  CAS  Google Scholar 

  9. Rubic T, Lorenz R L. Downregulated CD36 and ox-LDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10. Cardiovasc Res, 2006, 69(2): 527–535

    Article  PubMed  CAS  Google Scholar 

  10. Zerbinatti C, Gore R W. Uptake of modified low-density lipoproteins alters actin distribution and locomotor forces in macrophages. Am J Physiol Cell Physiol, 2003, 284(2): 555–561

    Google Scholar 

  11. Murphy J E, Tedbury P R, Homer-Vanniasinkam S, Warlker J, Ponnambalam S. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis, 2005, 182(1): 1–15

    Article  PubMed  CAS  Google Scholar 

  12. Ohashi R, Mu H, Yao Q, Chen C. Atherosclerosis: immunopathogenesis and immunotherapy. Med Sci Monit, 2004, 10(11): RA255–RA260

    PubMed  Google Scholar 

  13. Greaves D, Gordon S. Recent insights into the biology of macrophage scavenger receptors. J lipid Res, 2005, 46(1): 11–20

    Article  PubMed  CAS  Google Scholar 

  14. Lucas A D, Greaves D R. Atherosclerosis: role of chemokines and macrophages. Expert Rev Mol Med, 2001, 3(25): 1–18

    Article  PubMed  CAS  Google Scholar 

  15. Mostafa Mtairag E, Chollet-Martin S, Oudghiri M, Laquay N, Jacob M P, Michel J B, Feldman L J. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. Cardiovas Res, 2001, 49(4): 882–890

    Article  CAS  Google Scholar 

  16. Potteaux S, Esposito B, van Oostrom O, Brun V, Ardouin P, Groux H, Tedgui A, Mallat Z. Leukocyte-Derived Interleukin 10 Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice. Arterioscler Thromb Vasc Biol, 2004, 24(8): 1474–1478

    Article  PubMed  CAS  Google Scholar 

  17. Raychaudhuri B, Fisher C J, Farver C F, Malur A, Drazba J, Kavuru M S, Thomassen M J. Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine, 2000, 12(9): 1348–1355

    Article  PubMed  CAS  Google Scholar 

  18. Shanley T P, Vasi N, Denenberg A. Regulation of chemokine expression by IL-10 in lung inflammation. Cytokine, 2000, 12(7): 1054–1064

    Article  PubMed  CAS  Google Scholar 

  19. Amico G D, Frascaroli G, Bianchi G, Transidico P, Doni A, Vecchi A, Sozzani S, Allavena P, Mantovani A. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nature Immunology, 2000, 1(5): 387–391

    Article  PubMed  Google Scholar 

  20. Peiser L, Winther M, Makepeace K, Hollinshead M, Coull P, Plested J, Kodama T, Moxon E, Gordon S. The class A macrophage scavenger receptor is a major pattern recognition receptor for nesseria meningititdis which is independent of lipopolysaccharide and not required for secretory responses. Infect Immun, 2002, 70(10): 5346–5354

    Article  PubMed  CAS  Google Scholar 

  21. van Berkel T, Out R, Hoekstra M, Kuiper J, Biessen E, van Eck M. Scavenger receptors: friend or foe in atherosclerosis. Curr Opin Lipidol, 2005, 16(5): 525–535

    Article  PubMed  Google Scholar 

  22. Mallat Z, Besnard S, Duriez M, Deeluze V, Emmanuel F Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A. Protective role of IL-10 in atherosclerosis. Circ Res, 1999, 85(8): e 17–24

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yalei Dai.

Additional information

__________

Translated from Journal of Tongji University (Medical Science), 2007, 28(1): 1–5 [译自: 同济大学学报(医学版)]

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, F., Dai, Y., Xu, T. et al. Effect of IL-10 on formation of foam cell induced by ox-LDL. Front. Med. China 2, 298–302 (2008). https://doi.org/10.1007/s11684-008-0057-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-008-0057-3

Keywords

Navigation